A recent study published in JNCI Cancer Spectrum in January 2020 found 9/11 first responders have a significantly higher incidence of Leukemia. Leukemia is a type of cancer that affects the blood and bone marrow. Though the exact causes have yet to be identified, risk factors for the onset of the diseases include exposure to chemicals such as benzene, which was one of the many toxins composing the dust that covered Lower Manhattan on 9/11.
This is the first report in almost two decades that has detected higher risks of Leukemia among first responders who were exposed to 9/11 toxins. However, Leukemia can take years to develop after exposure to a carcinogen; this may explain why it is only now that we are starting to see higher rates.
The different types of Leukemia include:
- Acute Lymphoblastic Leukemia
- Acute Myeloid Leukemia
- Chronic Lymphocytic Leukemia
- Hairy Cell Leukemia
- Large Granular Lymphocytic Leukemia
Leukemia is a covered condition under the World Trade Center Health Program, which provides benefits and coverage for medical care and treatments. Victim Compensation Fund payouts will range depending on the case and the stage of Leukemia presented.
Slater Slater Schulman LLP is dedicated to the representation of individuals who have been injured or have loved ones who have been injured by exposure from the toxic debris of 9/11. Our firm is handling litigation related to these claims nationwide.
If you or someone you love was diagnosed with a 9/11-related type of Leukemia, please contact Slater Slater Schulman LLP for a free consultation by filling out the form on this page or by calling our office at (800) 251-6990.